Neovantage Bio-Technology Private Limited

Develops biotech buildings and land parcels in Hyderabad's biotech cluster.

2016 | Rangareddy, Telangana (India) | Active
Last Updated:

Neovantage Bio-Technology Profile

Key Indicators

  • Authorised Capital ₹ 12.50 Cr
  • Paid Up Capital ₹ 9.82 Cr
  • Company Age 8 Year, 7 Months
  • Last Filing with ROC 31 Mar 2024
  • Open Charges ₹ 63.00 Cr
  • Satisfied Charges ₹ 361.60 Cr
  • Revenue Growth 146.35%
  • Profit Growth -21.34%
  • Ebitda 114.08%
  • Net Worth -22.21%
  • Total Assets -8.00%

About Neovantage Bio-Technology

Neovantage Bio-Technology Private Limited (NBPL) is a Private Limited Indian Non-Government Company incorporated in India on 09 July 2016 (Eight years and seven months 26 days old ). Its registered office is in Rangareddy, Telangana, India.

The Company is engaged in the Financial Services Industry.

The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 12.50 Cr and a paid-up capital of Rs 9.82 Cr.

The company currently has active open charges totaling ₹63.00 Cr. The company has closed loans amounting to ₹361.60 Cr, as per Ministry of Corporate Affairs (MCA) records.

Shilpi Chowdhary and Chandan Mishra serve as directors at the Company.

Company Details

  • Location

    Rangareddy, Telangana, India

  • Telephone

    +91-XXXXXXXXXX

  • Email Address

  • Website

    -

  • Social Media
    -

Corporate Identity Details

  • CIN/LLPIN

    U74999TG2016PTC110776

  • Company No.

    110776

  • Company Classification

    Private Limited Indian Non-Government Company

  • Incorporation Date

    09 Jul 2016

  • Date of AGM

    26 Sep 2024

  • Date of Balance Sheet

    31 Mar 2024

  • Listing Status

    Unlisted

  • ROC Code

    Roc Hyderabad

Industry

Financial Services

Who are the key members and board of directors at Neovantage Bio-Technology?

Board Members (2)

NameDesignationAppointment DateStatus
Shilpi Chowdhary Country flag representing In Director 10-Jul-2018Current
Chandan Mishra Country flag representing In Additional Director 17-Oct-2024Current

Financial Performance of Neovantage Bio-Technology.

Neovantage Bio-Technology Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 146.35% increase. The company also saw a substantial fall in profitability, with a 21.34% decrease in profit. The company's net worth observed a substantial decline by a decrease of 22.21%.

Neovantage Bio-Technology revenue growth over time
Neovantage Bio-Technology profit and loss trends over time
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023)YOY Growth
(FY 2022)(FY 2021)(FY 2020)(FY 2019)
Total Revenue
146.35%
Revenue from Operations
302.40%
Total Assets
-8.00%
Profit or Loss
-21.34%
Net Worth
-22.21%
EBITDA
114.08%

What is the Ownership and Shareholding Structure of Neovantage Bio-Technology?

In 2021, Neovantage Bio-Technology had a promoter holding of 100.00%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Indicator graph

Charges (Loans)

Open Charges

₹63.00 Cr

Satisfied Charges

₹361.60 Cr

Charges Breakdown by Lending Institutions

  • The Hongkong And Shanghai Banking Corporation Limited : 63.00 Cr

Latest Charge Details

DateLenderAmountStatus
31 Oct 2022The Hongkong And Shanghai Banking Corporation Limited₹63.00 CrOpen
17 Dec 2019Others₹69.60 CrSatisfied
07 Sep 2018Others₹70.00 CrSatisfied
27 Sep 2016Idbi Trusteeship Services Limited₹54.50 CrSatisfied
27 Sep 2016Idbi Trusteeship Services Limited₹167.50 CrSatisfied

How Many Employees Work at Neovantage Bio-Technology?

Unlock and access historical data on people associated with Neovantage Bio-Technology, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee growth trends for Neovantage Bio-Technology Private Limited

Deals i

Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Neovantage Bio-Technology, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Neovantage Bio-Technology's trajectory.

Rating

Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Latest Updates, News, and FAQs on Neovantage Bio-Technology

Recent activity within the organization

  • Director Appointment

    Chandan Kumar Mishra was appointed as a Additional Director was appointed as a Additional Director on 17 Oct 2024 & has been associated with this company since 4 months 18 days .

  • Annual General Meeting

    Neovantage Bio-Technology Private Limited last Annual general meeting of members was held on 26 Sep 2024 as per latest MCA records.

  • Balance Sheet

    Neovantage Bio-Technology Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad.

  • Charges

    A charge with The Hongkong And Shanghai Banking Corporation Limited amounted to Rs. 63.00 Cr with Charge ID 100642285 was registered on 31 Oct 2022.

  • Charges

    A charge registered on 17 Dec 2019 via Charge ID 100314853 with Others was fully satisfied on 21 Sep 2022.

  • Charges

    A charge with Others of Rs. 69.60 Cr registered on 17 Dec 2019 with Charge ID 100314853 was modified on 19 Oct 2020.

Frequently asked questions

  • What is the Incorporation or founding date of Neovantage Bio-Technology Private Limited?

    Neovantage Bio-Technology Private Limited was incorporated on 09 Jul 2016.

  • What is authorized share capital and paid-up capital of Neovantage Bio-Technology Private Limited?

    The authorized share capital of Neovantage Bio-Technology Private Limited is ₹ 12.50 Cr and paid-up capital is ₹ 9.82 Cr.

  • Who are the current board members & directors of Neovantage Bio-Technology Private Limited?

    Currently 2 directors are associated with Neovantage Bio-Technology Private Limited.

    • Shilpi Chowdhary
    • Chandan Kumar Mishra
  • What is the registered address of Neovantage Bio-Technology Private Limited?

    As per Ministry of Corporate Affairs (Mca), the registered address of Neovantage Bio-Technology Private Limited is Building-450 Genome Valley Turkapally (V), Shamirpet Mandal India, Hyderabad, Telangana, 500078.

  • What is the corporate identification number (CIN) and company number of Neovantage Bio-Technology Private Limited?

    The corporate identification number (CIN) of Neovantage Bio-Technology Private Limited is U74999TG2016PTC110776 and the company number is 110776 as per Ministry of Corporate Affairs (MCA).

  • What has been the recent revenue trend for Neovantage Bio-Technology Private Limited?

    According to the financial reports for the fiscal year 2022, the revenue trend for Neovantage Bio-Technology Private Limited has risen by 146.35%.

  • What change has been observed in the net worth of Neovantage Bio-Technology Private Limited, and by what percentage?

    The financial reports for the fiscal year 2022 indicates that The net worth of Neovantage Bio-Technology Private Limited has experienced an downturn of -22.21%.

  • What are the total open charges for Neovantage Bio-Technology Private Limited?

    As per the financial statements for fiscal Year 2022, The total open charges for Neovantage Bio-Technology Private Limited amount to ₹ 63.00 Cr.

  • When was the last Balance Sheet of Neovantage Bio-Technology Private Limited filed with the ROC?

    The most recent Balance Sheet for Neovantage Bio-Technology Private Limited was filed with the ROC on 31 Mar 2024.

People also Viewed

Similar Companies Based on Real Estate Financing